Aquatic Capital Management Reduces CME Group Stake

Institutional investor sells nearly 5,000 shares of financial services provider

Mar. 15, 2026 at 8:48am

Got story updates? Submit your updates here. ›

Aquatic Capital Management LLC, an institutional investor, reduced its position in CME Group Inc. (NASDAQ:CME) by 5.4% in the third quarter, selling 4,799 shares of the financial services provider's stock. The firm now owns 83,813 shares of CME Group, valued at $22.6 million at the end of the reporting period.

Why it matters

CME Group operates some of the world's largest derivatives exchanges, including the Chicago Mercantile Exchange, Chicago Board of Trade, and NYMEX. As a major institutional investor, Aquatic Capital Management's trading activity in CME Group shares provides insight into market sentiment and institutional positioning around this key financial services company.

The details

According to the report, Aquatic Capital Management sold 4,799 shares of CME Group stock in the third quarter, reducing its total position to 83,813 shares. The firm cited unspecified reasons for the share sale, which represented a 5.4% decrease in its CME Group holdings. CME Group's stock price has fluctuated in recent quarters, trading between $248.53 and $329.16 over the past 12 months.

  • Aquatic Capital Management sold the 4,799 CME Group shares in the third quarter of 2025.

The players

Aquatic Capital Management LLC

An institutional investor that manages a portfolio of financial assets, including shares of CME Group Inc.

CME Group Inc.

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange, Chicago Board of Trade, and NYMEX.

Got photos? Submit your photos here. ›

The takeaway

Aquatic Capital Management's reduction in its CME Group stake suggests the institutional investor sees potential headwinds or opportunities elsewhere in the market, though the specific reasons behind the share sale are unclear. CME Group's diverse derivatives offerings and central role in global financial markets make it a closely watched stock among institutional investors.